Albany Molecular Res (AMRI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2016 | 12-2015 | 09-2015 | 06-2015 | 03-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -10,067 | -2,301 | -4,086 | 84 | -2,223 |
| Depreciation Amortization | 9,493 | 29,519 | 20,169 | 14,911 | 5,753 |
| Income taxes - deferred | 2,258 | -2,915 | -1,112 | 826 | 303 |
| Accounts receivable | 15,484 | -9,353 | 12,442 | 43 | 1,186 |
| Accounts payable and accrued liabilities | N/A | N/A | 2,052 | 1,894 | N/A |
| Other Working Capital | 6,068 | -599 | 10,316 | -768 | -4,076 |
| Other Operating Activity | -11,538 | 25,277 | -1,286 | 3,022 | 3,428 |
| Operating Cash Flow | $11,698 | $39,628 | $38,495 | $20,012 | $4,371 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -11,616 | -22,010 | -13,628 | -7,510 | -4,096 |
| Net Acquisitions | N/A | -199,580 | -145,656 | -59,656 | -59,317 |
| Purchase Sale Intangibles | -103 | -126 | -54 | -54 | -54 |
| Other Investing Activity | -103 | -126 | -54 | -54 | -54 |
| Investing Cash Flow | $-11,719 | $-221,716 | $-159,338 | $-67,220 | $-63,467 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 269,661 | 237,000 | 39,000 | 39,000 |
| Debt Repayment | -5,805 | -81,864 | -76,799 | -376 | -34 |
| Common Stock Issued | 620 | 3,458 | 2,818 | 2,087 | 1,038 |
| Common Stock Repurchased | -714 | -824 | -779 | -617 | -477 |
| Other Financing Activity | -34 | -5,015 | -7,185 | 2,768 | 1,553 |
| Financing Cash Flow | $-5,933 | $185,416 | $155,055 | $42,862 | $41,080 |
| Exchange Rate Effect | 804 | -980 | -1,745 | -93 | -464 |
| Beginning Cash Position | 49,343 | 46,995 | 46,995 | 46,995 | 46,995 |
| End Cash Position | 44,193 | 49,343 | 79,462 | 42,556 | 28,515 |
| Net Cash Flow | $-5,150 | $2,348 | $32,467 | $-4,439 | $-18,480 |
| Free Cash Flow | |||||
| Operating Cash Flow | 11,698 | 39,628 | 38,495 | 20,012 | 4,371 |
| Capital Expenditure | -11,629 | -22,041 | -13,659 | -7,541 | -4,127 |
| Free Cash Flow | 69 | 17,587 | 24,836 | 12,471 | 244 |